GTBP
GT Biopharma·NASDAQ
--
--(--)
--
--(--)
GTBP fundamentals
GT Biopharma (GTBP) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.55 (YoY +74.65%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.55
+74.65%
Report date
Aug 14, 2025
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
GT Biopharma (GTBP) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
GT Biopharma (GTBP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
GT Biopharma (GTBP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
GT Biopharma (GTBP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does GT Biopharma (GTBP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track GT Biopharma (GTBP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does GT Biopharma do and what are its main business segments?What were the key takeaways from GT Biopharma's earnings call?What is the revenue and EPS growth rate for GT Biopharma year over year?What is GT Biopharma's gross profit margin?Did GT Biopharma beat or miss consensus estimates last quarter?What were the key takeaways from GT Biopharma’s earnings call?What guidance did GT Biopharma's management provide for the next earnings period?What is the market's earnings forecast for GT Biopharma next quarter?
